immune modulators
Showing 1 - 25 of >10,000
Stress Trial in Plymouth (Chaga Mushroom, Algae Extract, Black Cumin Seed Oil)
Completed
- Stress
- Chaga Mushroom
- +5 more
-
Plymouth, Massachusetts3 Waves Wellness, LLC
Aug 18, 2022
COVID-19 Trial in Viña Del Mar (MC 3x3, Placebo)
Not yet recruiting
- COVID-19
- MC 3x3
- Placebo
-
Viña Del Mar, Valparaiso, ChileHospital Gustavo Fricke
Jul 18, 2022
MS Patients Treated With Sphingosine-1-phosphate Receptor
Recruiting
- Multiple Sclerosis
- S1PR analysis on immune cells
-
Bern, SwitzerlandNeurology department
Apr 12, 2023
Cancer Trial in Toronto (Nurse Monitoring)
Not yet recruiting
- Cancer
- Nurse Monitoring
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 21, 2022
Melanoma, NSCLC, Hepatocellular Carcinoma Trial in Pittsburgh (Nivolumab or Pembrolizumab (dependent upon approved indication),
Recruiting
- Melanoma
- +7 more
- Nivolumab or Pembrolizumab (dependent upon approved indication)
- +2 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 10, 2022
Systemic Inflammatory Response Syndrome Trial in Assiut (solumedrol, Dexamethasone phosphate)
Completed
- Systemic Inflammatory Response Syndrome
- solumedrol
- Dexamethasone phosphate
-
Assiut, Assuit, EgyptAssuit university hospital
Jun 11, 2021
Immune Modulators and IVF
Terminated
- In Vitro Fertilization
- Observational
-
New York, New YorkRonald O. Perelman and Claudia Cohen Center for Reproductive Med
Sep 11, 2019
Detection and Characterization of Host Defense Defects
Recruiting
- Immune Defects
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Glioblastoma Multiforme of Brain, Glioblastoma Multiforme Trial in Shenzhen (Antigen-specific IgT cells)
Enrolling by invitation
- Glioblastoma Multiforme of Brain
- Glioblastoma Multiforme
- Antigen-specific IgT cells
-
Shenzhen, Guangdong, China
- +1 more
Nov 23, 2021
Immune-mediated Diseases
Recruiting
- Primary Immunodeficiency
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Epileptic Seizures Related to Drugs Trial in Xi'an (minocycline)
Enrolling by invitation
- Epileptic Seizures Related to Drugs
-
Xi'an, Shaanxi, ChinaXijingHospital
Jul 21, 2023
Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative
Completed
- Colitis, Ulcerative
- No Intervention
-
Ansan-si, Korea, Republic of
- +14 more
Mar 30, 2022
MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)
Not yet recruiting
- MSS
- Rectal Cancer
- Sintilimab with Interleukin-2
- (no location specified)
Nov 1, 2023
COVID-19 Vaccine Response in Treated MS Patients
Recruiting
- Multiple Sclerosis
- Healthy
- Blood draw
-
Boston, MassachusettsBrigham MS Center
Jul 26, 2022
Renal Cancer Metastatic Trial in Reggio Emilia (Nivolumab)
Completed
- Renal Cancer Metastatic
-
Reggio Emilia, ItalyStruttura Complessa di OncologiaIRCCS- Istituto in Tecnologie Av
May 1, 2022
Colorectal Cancer Trial in China (Huaier granule)
Not yet recruiting
- Colorectal Cancer
- Huaier granule
-
Harbin, Heilongjiang, China
- +8 more
Oct 15, 2023
Refractory or Recurrent Solid Tumor Trial in France (Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort,
Not yet recruiting
- Refractory or Recurrent Solid Tumor
- Spartalizumab in Pediatric cohort
- +3 more
-
Angers, France
- +8 more
Mar 9, 2022
MicroRNAs and Cytokines in Peri-Implantitis Tissue
Active, not recruiting
- Peri-implantitis
-
Baghdad, IraqMunir
Mar 14, 2023
Gulf War Illness Trial in Birmingham (Boswellia Serrata, Curcumin, Epimedium)
Active, not recruiting
- Gulf War Illness
- Boswellia Serrata
- +9 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Nov 17, 2021